ZITADEL combines the ease of Auth0 and the versatility of Keycloak.**Actions**, introduced in ZITADEL **1.42.0** on the API and **1.56.0** for Console, is a feature, where users with role.`ORG_OWNER` are able to create Javascript Code, which is invoked by the system at certain points during the login. **Actions**, for example, allow creating authorizations (user grants) on newly created users programmatically. Due to a missing authorization check, **Actions** were able to grant authorizations for projects that belong to other organizations inside the same Instance. Granting authorizations via API and Console is not affected by this vulnerability. There is currently no known workaround, users should update.
Published 2022-08-31 23:15:08
Updated 2022-09-09 15:12:45
Source GitHub, Inc.
View at NVD,   CVE.org

Exploit prediction scoring system (EPSS) score for CVE-2022-36051

0.19%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 55 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2022-36051

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
8.8
HIGH CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
2.8
5.9
NIST
8.7
HIGH CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:N
2.3
5.8
GitHub, Inc.

CWE ids for CVE-2022-36051

  • Product A handles inputs or steps differently than Product B, which causes A to perform incorrect actions based on its perception of B's state.
    Assigned by: security-advisories@github.com (Secondary)
  • The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check. This allows attackers to bypass intended access restrictions.
    Assigned by: nvd@nist.gov (Primary)

References for CVE-2022-36051

Products affected by CVE-2022-36051

This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!